Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Position Statement by the Saudi Heart Failure Working Group of the Saudi Heart Association on the Management of Advanced Heart Failure in Saudi Arabia.

Created on 14 Nov 2026

Authors

Ibrahim Jelaidan, Abeer Bakhsh, Ammar G Chaudhary, Ebtisam Alkhattaby, Fahmi AlKaf, Feras Khaliel, Ismail Raslan, Mohammed Alreshidan, Mosaad Alhussein, Waleed Alhabeeb

Published in

Journal of the Saudi Heart Association. Volume 38. Issue 2. Pages 21. Epub Jul 09, 2026.

Abstract

Heart failure (HF) is a leading cause of morbidity and mortality in Saudi Arabia. Despite remarkable progress in guideline-directed medical therapy, a significant proportion of patients progress to advanced HF and require evaluation for heart transplantation or mechanical circulatory support (MCS). In response to this growing burden, the Saudi Heart Association (SHA) developed recommendations to guide identification, timely referral, and optimal management of candidates for advanced HF therapies in Saudi Arabia.
A multidisciplinary panel of 10 HF experts from Saudi Arabia convened for a series of structured virtual meetings to review local and international evidence. The panel integrated Saudi-specific clinical practice patterns and healthcare considerations into the deliberation process. Consensus was achieved through discussion and majority agreement. Recommendations were formulated using the SHA methodology, supported by a comprehensive literature review of published evidence.
The SHA consensus establishes a structured, comprehensive framework for recognizing advanced HF, optimizing guideline-directed therapy, and determining candidacy for heart transplantation or MCS in tertiary and quaternary centers in Saudi Arabia. The document emphasizes timely prognostic stratification using clinical indicators and standardized tools such as INTERMACS and SCAI classifications. Referral pathways and multidisciplinary coordination are delineated to facilitate efficient evaluation and timely intervention. These recommendations aim to minimize delays in referral, expand access to advanced HF therapies and improve patient outcomes across Saudi Arabia.

PMID:
42899058
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement